Security key
59102M104
- Type / Class
- Equity / COM
- Total 13F shares
- 6,750,362
- Share change
- -2,517,694
- Total reported value
- $9,989,847
- Price per share
- $1.48
- Number of holders
- 67
- Value change
- -$3,542,499
- Number of buys
- 34
- Number of sells
- 46
Report period
Q2 2025
Institutions
67
Top holders
10
MGX full security history
Newer quarter: Q3 2025
Previous quarter: Q1 2025
Metagenomi Therapeutics, Inc. SEC filings
Metagenomi Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 59102M104
Recent filing periods:
Top shareholders of MGX - Metagenomi Therapeutics, Inc. - COM (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BAYER HEALTHCARE LLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
4,050,997
|
$11,666,871 | — | 13 Feb 2024 | |
| Novo Holdings A/S |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
1,739,175
|
$5,008,824 | — | 09 Feb 2024 | |
| Sebastian Bernales |
3/4/5
|
Director |
—
mixed-class rows
|
3,147,422
mixed-class rows
|
$6,620,950 | — | 01 Apr 2024 | |
| BlackRock, Inc. |
13F
|
Company |
—
class O/S missing
|
1,544,073
|
$2,099,940 | — | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
—
class O/S missing
|
1,457,187
|
$1,981,774 | — | 31 Mar 2025 | |
| PFM Health Sciences, LP |
13F
|
Company |
—
class O/S missing
|
885,803
|
$1,204,692 | — | 31 Mar 2025 | |
| Sozo Ventures GP II, L.P. |
13F
|
Company |
—
class O/S missing
|
581,577
|
$1,006,128 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
—
class O/S missing
|
619,574
|
$842,620 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
—
class O/S missing
|
566,927
|
$771,021 | — | 31 Mar 2025 | |
| Catalio Capital Management, LP |
13F
|
Company |
—
class O/S missing
|
528,993
|
$719,430 | — | 31 Mar 2025 | |
| Peapod Lane Capital LLC |
13F
|
Company |
—
class O/S missing
|
352,457
|
$479,342 | — | 31 Mar 2025 | |
| PURA VIDA INVESTMENTS, LLC |
13F
|
Company |
—
class O/S missing
|
264,391
|
$359,572 | — | 31 Mar 2025 | |
| Simon Harnest |
3/4/5
|
Title: Chief Investment Officer and Senior Vice President of Strategy |
—
mixed-class rows
|
171,239
mixed-class rows
|
$353,272 | — | 01 Apr 2024 | |
| NORGES BANK |
13F
|
Company |
—
class O/S missing
|
252,310
|
$343,142 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
—
class O/S missing
|
218,550
|
$297,228 | — | 31 Mar 2025 | |
| Simren Delaney |
3/4/5
|
Title: Vice President of Intellectual Property and Legal Operations |
—
mixed-class rows
|
123,037
mixed-class rows
|
$270,409 | — | 01 Apr 2024 | |
| MORGAN STANLEY |
13F
|
Company |
—
class O/S missing
|
193,753
|
$263,503 | — | 31 Mar 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
—
class O/S missing
|
185,108
|
$251,747 | — | 31 Mar 2025 | |
| HHLR ADVISORS, LTD. |
13F
|
Company |
—
class O/S missing
|
150,699
|
$204,951 | — | 31 Mar 2025 | |
| Luis Borges |
3/4/5
|
Chief Scientific Officer |
—
mixed-class rows
|
360,766
mixed-class rows
|
$199,630 | — | 01 Apr 2024 | |
| Sarah B. Noonberg |
3/4/5
|
Chief Medical Officer |
—
mixed-class rows
|
193,135
mixed-class rows
|
$190,986 | -$9,168 | 06 Jun 2025 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
—
class O/S missing
|
134,978
|
$183,570 | — | 31 Mar 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
—
class O/S missing
|
109,968
|
$149,556 | — | 31 Mar 2025 | |
| Good Life Advisors, LLC |
13F
|
Company |
—
class O/S missing
|
100,000
|
$136,000 | — | 31 Mar 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
—
class O/S missing
|
99,600
|
$135,456 | — | 31 Mar 2025 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
—
class O/S missing
|
98,700
|
$134,232 | — | 31 Mar 2025 | |
| Resolute Advisors LLC |
13F
|
Company |
—
class O/S missing
|
89,944
|
$122,324 | — | 31 Mar 2025 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
—
class O/S missing
|
87,719
|
$119,298 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
—
class O/S missing
|
79,864
|
$108,615 | — | 31 Mar 2025 | |
| Verition Fund Management LLC |
13F
|
Company |
—
class O/S missing
|
72,125
|
$98,090 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
—
class O/S missing
|
67,751
|
$92,141 | — | 31 Mar 2025 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
—
class O/S missing
|
66,182
|
$90,008 | — | 31 Mar 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
—
class O/S missing
|
65,753
|
$89,424 | — | 31 Mar 2025 | |
| Nuveen, LLC |
13F
|
Company |
—
class O/S missing
|
63,248
|
$86,017 | — | 31 Mar 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
—
class O/S missing
|
58,348
|
$79,353 | — | 31 Mar 2025 | |
| BBR PARTNERS, LLC |
13F
|
Company |
—
class O/S missing
|
53,403
|
$72,628 | — | 31 Mar 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
—
class O/S missing
|
50,387
|
$68,526 | — | 31 Mar 2025 | |
| Diametric Capital, LP |
13F
|
Company |
—
class O/S missing
|
49,285
|
$67,027 | — | 31 Mar 2025 | |
| Fortitude Advisory Group L.L.C. |
13F
|
Company |
—
class O/S missing
|
36,790
|
$54,449 | — | 31 Mar 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
—
class O/S missing
|
33,250
|
$45,220 | — | 31 Mar 2025 | |
| SG Americas Securities, LLC |
13F
|
Company |
—
class O/S missing
|
33,019
|
$45,000 | — | 31 Mar 2025 | |
| Virtu Financial LLC |
13F
|
Company |
—
class O/S missing
|
31,658
|
$43,000 | — | 31 Mar 2025 | |
| BARCLAYS PLC |
13F
|
Company |
—
class O/S missing
|
28,848
|
$39,234 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
—
class O/S missing
|
28,830
|
$39,209 | — | 31 Mar 2025 | |
| SEI INVESTMENTS CO |
13F
|
Company |
—
class O/S missing
|
27,751
|
$37,741 | — | 31 Mar 2025 | |
| PRELUDE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
—
class O/S missing
|
25,556
|
$34,756 | — | 31 Mar 2025 | |
| BROWN ADVISORY INC |
13F
|
Company |
—
class O/S missing
|
25,006
|
$34,008 | — | 31 Mar 2025 | |
| Pinnacle Wealth Planning Services, Inc. |
13F
|
Company |
—
class O/S missing
|
24,583
|
$33,433 | — | 31 Mar 2025 | |
| PRUDENTIAL FINANCIAL INC |
13F
|
Company |
—
class O/S missing
|
24,525
|
$33,354 | — | 31 Mar 2025 | |
| Green Alpha Advisors, LLC |
13F
|
Company |
—
class O/S missing
|
24,029
|
$32,679 | — | 31 Mar 2025 |
Institutional Holders of Metagenomi Therapeutics, Inc. - COM (MGX) as of Q2 2025
As of 30 Jun 2025,
Metagenomi Therapeutics, Inc. - COM (MGX) was held by
67 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,750,362 shares.
The largest 10 holders included
VANGUARD GROUP INC, Sozo Ventures GP II, L.P., Catalio Capital Management, LP, Peapod Lane Capital LLC, MILLENNIUM MANAGEMENT LLC, BlackRock, Inc., GEODE CAPITAL MANAGEMENT, LLC, NORGES BANK, MORGAN STANLEY, and Good Life Advisors, LLC.
This page lists
68
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
76
Q2 2025 holders
67
Holder diff
-9
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.